[1]顾敏晔,沈 燕,李福刚.基于CLSI-M43国际标准改良的Mycoview-AST试剂盒检测性能评估[J].现代检验医学杂志,2016,31(02):105-107,111.[doi:10.3969/j.issn.1671-7414.2016.02.031]
　GU Min-ye,SHEN Yan,LI Fu-gang.Detection Performance Evaluation of the Mycoview-AST Kits That Was Improved Based on the International Standard CLSI M43-A[J].Journal of Modern Laboratory Medicine,2016,31(02):105-107,111.[doi:10.3969/j.issn.1671-7414.2016.02.031]
点击复制

基于CLSI-M43国际标准改良的Mycoview-AST试剂盒检测性能评估()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第31卷
期数:
2016年02期
页码:
105-107,111
栏目:
研究简报·实验技术
出版日期:
2016-06-01

文章信息/Info

Title:
Detection Performance Evaluation of the Mycoview-AST Kits That Was Improved Based on the International Standard CLSI M43-A
作者:
顾敏晔1; 2; 沈 燕1; 李福刚1
1.上海奥普生物医药有限公司, 上海 201201; 2.复旦大学生命科学院,上海 200433
Author(s):
GU Min-ye1; 2; SHEN Yan1; LI Fu-gang1
1.Shanghai Upper Biological Medicine Co.LTD,Shanghai 201201,China; 2.College of Life Science of Fudan University,Master of Bioengineer candidate,Shanghai 200433,China
关键词:
美国临床标准化协会M43-A;  解脲支原体;  人型支原体
分类号:
R446
DOI:
10.3969/j.issn.1671-7414.2016.02.031
文献标志码:
A
摘要:
目的 基于美国临床标准化协会(clinical and laboratory standards institute,CLSI)M43国际标准改进的泌尿生殖道支原体Mycoview-AST试剂盒检测性能评估。方法 以法国MYCOFAST○Rrevolution支原体试剂盒为比对标准,用CLSI-M43规定的质控株和有关指标及60例临床标本对新改进的试剂盒性能进行评估。结果 Mycoview-AST试剂盒以质控菌株检测的药敏结果与MYCOFAST11○Rrevolution试剂盒一致。60例临床标本,阴性标本37例,解脲支原体(Uu)阳性16例,人型支原体(Mh)阳性5例,Uu与Mh均阳性的标本2例。两种试剂盒Uu和Mh的鉴定结果一致。23例阳性标本的药敏结果共161个,与进口比对试剂MYCOFAST○R比对,154个结果符合,药敏结果符合率为95.6%(154/161)。结论 基于CLSI-M43国际标准改进后的Mycoview-AST试剂盒检测性能与国际知名品牌MYCOFAST○Rrevolution试剂盒相当。
Abstract:
Objective To evaluate the performance of the Mycoview-AST kits,which was improved based on the international standard CLSI-M43.Methods Evaluated the performance of the improved kit with the control strains which were assigned by CLSI-M43 and 60 clinical specimens,compared with MYCOFAST○R revolution kit as the standard.Results The results of the antibiotic susceptibility tests with the control stain were in accordance with that of MYCOFAST○R revolution kit.In the 60 clinical specimens,the identification resultsof mycoplasma in these two kits were corresponding.The coincidence rate of theantibiotic susceptibility tests with the clinical specimens in these two kits was 95.6%(154/161).Conclusion The performance of the improved Mycoview-AST kits based on CLSI-M43 was equal to MYCOFAST○R revolution kit.

参考文献/References:

[1] 荣仕成,余伟香.泌尿生殖道感染的解脲支原体(Uu)培养及药敏分析[J].中国医药指南,2014,12(21):238. Rong SC,Yu WX.The culture and antibiotic sensitivity test of Uu inthe urinary and genital tract infection[J].Guide of China Medicine,2014,12(21):238.
[2] Redelinghuys MJ,Ehlers MM,Dreyer AW,et al.Co-mparison of the new Mycofast Revolution assay with a molecular assay for the detection of genital mycoplasmas from clinical specimens[J].BMC Infectious Diseases,2013(13):453.
[3] Waites KB,Crabb LB,Duffy DM.Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide,CEM-101[J].Antimicrobial Agents and Chemotherapy,2009,53(5):2139-2141.
[4] Clinical and Laboratory Standands Institute.Methods for antimicrobial susceptibility testing for human mycoplasmas; Approved guideline[S].Wayne:PA,CLSI M43-A,2011.
[5] Waites KB,Duffy LB,Bebear CM,et al.Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae,Mycoplasma hominis and Ureaplasma urealyticum[J].Journal of Clinil Microbiology,2012,50(11):3542-3547.
[6] Bebear CM,Barbeyrac BD,Pereyre S,et al.Activity of moxifloxacin against the urogenital Mycoplasmas Ureaplasma spp.Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis[J].ClinicalMicrobiology & Infection,2008,14(8):801-805.

备注/Memo

备注/Memo:
基金项目:上海医学即时检验产业技术创新联盟(11DZ0512200)。 作者简介:顾敏晔(1973-),女,学士,硕士研究生在读,副主任检验师,E-mail:lyxwan@live.cn。
更新日期/Last Update: 2016-02-20